3 studies found for:    20733306 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone XR
2 Not yet recruiting Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
Conditions: Mild Cognitive Impairment;   Insulin Resistance;   Diabetes Mellitus, Type 2
Interventions: Drug: Metformin;   Behavioral: Intensive Lifestyle Intervention;   Behavioral: Standard LIfestyle Recommendation
3 Completed Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone

Indicates status has not been verified in more than two years